ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
64,297.16
0.63%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Kyverna Therapeutics Inc (KYTX) Quote

Kyverna Therapeutics Inc

Kyverna Therapeutics Inc (KYTX)

NASDAQ
15.25
0.22
(1.46%)
Closed May 05 4:00PM
Delayed by 15 minutes
15.26
0.01
(0.07%)
After Hours: 7:59PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
15.25
Bid
13.96
Ask
24.90
Volume
459,649
14.81 Day's Range 16.44
13.96 52 Week Range 35.01
Market Cap
622.952M
Previous Close
15.03
Open
14.86
Last Trade
1
@
15.0294
Last Trade Time
Financial Volume
$ 6,968,614
VWAP
15.1607
Average Volume (3m)
408,914
Shares Outstanding
40,822,525
Dividend Yield
-
PE Ratio
-10.32
Earnings Per Share (EPS)
-1.48
Revenue
-
Net Profit
-60.37M

About Kyverna Therapeutics Inc

Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin... Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna¿s pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
kyvernatx.com
Headquarters
Dover, Delaware, USA
Founded
1970
Kyverna Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker KYTX. The last closing price for Kyverna Therapeutics was $15.03. Over the last year, Kyverna Therapeutics shares have traded in a share price range of $ 13.96 to $ 35.01.

Kyverna Therapeutics currently has 40,822,525 shares outstanding. The market capitalization of Kyverna Therapeutics is $622.95 million. Kyverna Therapeutics has a price to earnings ratio (PE ratio) of -10.32.

KYTX Latest News

More News

Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune Diseases

Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune...

April 11 2024
PR Newswire (US)

First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med

First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med PR Newswire EMERYVILLE, Calif., March 29, 2024 Two patients were treated...

March 29 2024
PR Newswire (US)

Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results

Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results PR Newswire EMERYVILLE, Calif., March 26, 2024 Advanced clinical development in two broad areas of...

March 26 2024
PR Newswire (US)

Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis

Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis PR Newswire EMERYVILLE, Calif., March 7, 2024 The...

March 07 2024
PR Newswire (US)

Kyverna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Kyverna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire EMERYVILLE, Calif., Feb. 12, 2024 EMERYVILLE...

February 12 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.5-3.174603174615.7516.6513.9666912715.47470195CS
4-6.91-31.182310469322.1624.9113.9641341218.34548309CS
12-14.9-49.419568822630.1530.7813.9640891423.84281097CS
26-19-55.474452554734.2535.0113.9644530024.44174947CS
52-19-55.474452554734.2535.0113.9644530024.44174947CS
156-19-55.474452554734.2535.0113.9644530024.44174947CS
260-19-55.474452554734.2535.0113.9644530024.44174947CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
zab zab 3 minutes ago
https://www.msn.com/en-us/news/politics/trump-media-s-auditor-hit-with-massive-fraud-charge-what-we-know/ar-AA1o8zgo
DJT
zab zab 3 minutes ago
https://www.msn.com/en-us/news/politics/trump-media-s-auditor-hit-with-massive-fraud-charge-what-we-know/ar-AA1o8zgo
Monksdream Monksdream 3 minutes ago
BOWL 10Q due 5/6
https://investorshub.advfn.com/uimage/uploads/2024/5/5/lyo[qIMG_8066.gif
BOWL
Roofus Roofus 4 minutes ago
I think Korenko would take anything at/over $1 billion ….

In terms of a buyout, a $1 billion buyout would also be about $2.50 per share.

If Korenko accepted a buyout, we would each get $2.50+ for our shares.

I know some are wanting to wait it out for a
RDGL
zab zab 4 minutes ago
https://www.msn.com/en-us/money/companies/trump-media-stock-tumbles-as-the-sec-charges-its-auditor-with-massive-fraud/ar-AA1o60dt
HD2001 HD2001 4 minutes ago
Here was the shift 2 weeks later we were an AI company but it was announced as big with no word on it since.https://www.otcmarkets.com/stock/XALL/news/Xalles-Expands-into-NFT-and-Crypto-Marketplaces?id=342903 Just like today everything is groundbreaking but there's never any updates what a mismanage
XALL
zab zab 4 minutes ago
https://www.msn.com/en-us/money/companies/trump-media-stock-tumbles-as-the-sec-charges-its-auditor-with-massive-fraud/ar-AA1o60dt
DJT
Jimmy Joe Jimmy Joe 4 minutes ago
Even a pickle is smarter.


Pickle is much smarter, as that little cutie rides with Troy to harvest gators in Swamp People.
Love that little cutie~!

Not sure what the agenda is for Mighty Mouse. So full of knowledge. The sharpest knife in the drawer accordi
TPTW
gitreal gitreal 4 minutes ago
Do you ever get tired of posting all that nonsense?

How do you perfect an Exchange that doesn't even exist?
AABB
Gmenfan Gmenfan 5 minutes ago
Hey Al, maybe if the women's rights groups would start defending the females that are being subjected to this idiocy the ones setting these asinine rules would take notice!
zab zab 5 minutes ago
https://www.msn.com/en-us/money/companies/trump-media-s-accounting-company-accused-of-massive-fraud/ar-BB1lRpvP?ocid=msedgntp&pc=U531&cvid=be7c9159fd1b4efbd0a62d3d6938aedd&ei=8

Trump's media company accused of massive fraud.
DJT
douginil douginil 6 minutes ago
Actually a nice article. Unfortunately defense contracting for a small firm has always been a feast of famine situation.
IAALF
zab zab 6 minutes ago
https://www.msn.com/en-us/money/companies/trump-media-s-accounting-company-accused-of-massive-fraud/ar-BB1lRpvP?ocid=msedgntp&pc=U531&cvid=be7c9159fd1b4efbd0a62d3d6938aedd&ei=8
Another day, another rip off by trump. That is what the new republican party represents, massive fraud.
Monksdream Monksdream 6 minutes ago
RKLB 10Q due 5/6
https://investorshub.advfn.com/uimage/uploads/2024/5/5/tjrfbIMG_8065.gif
RKLB
MightyX MightyX 7 minutes ago
Tradings practically halted..narratives are being pumped/dumped independent of trading now lmao
TPTW
pdmihopefull pdmihopefull 7 minutes ago
Hey allenc...tell that to the idiotic 4th grader who is posting on this board...even if management launches on the 17th... which I doubt...the football 🏈🏈🏈 post has been pushed farther away... añd the kicker has lost credibility...so the team will suffer into The trips ... no
KGKG
Inquirig Inquirig 10 minutes ago
Most likely another reverse split
NWBO
bigtalan bigtalan 10 minutes ago
Thanks docsetc , Sounds good Hopefully this all will work out . Again Thank you
ENZC
MightyX MightyX 10 minutes ago
And so? Doesn’t sound like big deal to you now all sudden lol figures
TPTW
dstock07734 dstock07734 11 minutes ago
What's your take on the combo trial of DCVax-L combined with CYT107 on three pediatric cancers? Would you agree the results are truly amazing? Don't tell me it is not DCVax-L because I am not three year ago. Have you seen me replying to the nonsense of ATL-DC is not DCVax-L you conjured up? It is so
NWBO
Monksdream Monksdream 11 minutes ago
FRPT. 10Q due 5/6
https://investorshub.advfn.com/uimage/uploads/2024/5/5/ussimIMG_8064.gif
FRPT
oilin07 oilin07 11 minutes ago
Take notes......1. Tim Gargaro, CFO, CPA, MBA
Mr. Gargaro has provided leadership to companies that range in size from $250 million to $5 Billion in revenue. This includes performing Chief Financial Officer (CFO) duties for five independent companies: three publicly traded, and two privately
BLLB
vinnie1965 vinnie1965 11 minutes ago
Hey gang Happy Sunday I was just wondering can anybody give me an honest answer about why Delfin hasn't gotten this to the end result of merging with TGLO.
TGLO
mkt_predictor mkt_predictor 12 minutes ago
I think it continues to churn upwards into the .003s this week. Could reach the .004s and maybe .005s but hope it trends sideways from there. We need a nice base of strong holders put in to make the move up to .01+. Let’s see what additional updates we get this month and hopefully the volume cont
BLLB

Your Recent History

NASDAQ
KYTX
Kyverna Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved